GLP-1 Receptor Agonists for Type 2 Diabetes and Their Role in Primary Care: An Australian Perspective

The ever-increasing number of drugs available to treat type 2 diabetes and the complexity of patients with this condition present a constant challenge when it comes to identifying the most appropriate treatment approach. The more recent glucagon-like peptide-1 receptor agonists (GLP-1RAs) are non-in...

Descripción completa

Detalles Bibliográficos
Autores principales: Rasalam, Roy, Barlow, John, Kennedy, Mark, Phillips, Pat, Wright, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612351/
https://www.ncbi.nlm.nih.gov/pubmed/31183762
http://dx.doi.org/10.1007/s13300-019-0642-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612351/
https://www.ncbi.nlm.nih.gov/pubmed/31183762
http://dx.doi.org/10.1007/s13300-019-0642-2

Ejemplares similares